Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis
Wolf, Erin, Rich, Nicole E., Marrero, Jorge A., Parikh, Neehar D., Singal, Amit G.·2021·Hepatology
Cited by (333)
Items 301–333 of 333
- Mining of Targeted Therapeutic Drugs for Hepatocellular Carcinoma based on Programmed Cell Death-related Features and Construction of an Imaging Histology Diagnostic ModelJuan Wang, Xiaoli Zhao, C.-J. Chen, H.-F. Li, Chunli Liu, Zhongfeng Cui, Guangming Li · 2025 · Current Topics in Medicinal Chemistry
- Should a Randomized Controlled Trial of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis Be Performed?Ian A.C. Rowe · 2025 · Springer eBooks
- Travel Distance and Insurance Status: Association With Treatment Access and Survival Among Patients With Hepatocellular CarcinomaMiho Akabane, Abdullah Altaf, Jun Kawashima, Yuki Imaoka, Timothy Michael Pawlik · 2025 · Journal of Surgical Oncology
- Present and future of systemic therapy for early and intermediate stages of hepatocellular carcinomaCarlos Alventosa Mateu, Juan José Urquijo Ponce · 2025 · Revisiones en cáncer
- Underuse of hepatocellular carcinoma surveillance in patients with cirrhosis: a nested cohort studyPascal Caillet, Frédéric Balusson, Nathalie Ganne‐Carrié, Emmanuel Oger, Charlotte E. Costentin, O. Ganry · 2025 · medRxiv
- Evaluating hepatocellular carcinoma (HCC) surveillance through an early diagnostic centre: An implementation science approach at a tertiary hepatology centre in EnglandHamzah Z. Farooq, Kevin Galono, Leila Reid, Janet Dearden, Graham R. Foster · 2025 · Clinical Medicine
- A contemporary review of care gaps in hepatocellular carcinoma surveillanceNikki K. Duong, Veronica Nguyen, Mindie H. Nguyen · 2025 · Expert Review of Gastroenterology & Hepatology
- Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North CarolinaChristine D. Hsu, Louise M. Henderson, Bradford E. Jackson, Christopher D. Baggett, Michele Jönsson Funk, Andrew F. Olshan, Parul Gupta, A. Sidney Barritt, Hanna Kelly Sanoff, Stephanie B. Wheeler et al. · 2025 · North Carolina Medical Journal
- Diagnostic Performance Comparison of AFP, PIVKA-II, GALAD Model, and ASAP Model Across Two Chemiluminescence Immunoassay Platforms for Hepatocellular CarcinomaYuan Huang, Rui Ding, Yue Cui, Peng Li, Jie Niu, Guan-Hua Wang, Xu-Zhen Qin · 2026 · Journal of Hepatocellular Carcinoma
- Special PopulationsRobert J. Wong, Massimo G. Colombo, Elisa Pinto, Patrizia Burra · 2026 · Clinics in Liver Disease
- Expert Practical Recommendations for Hepatocellular CarcinomaFeng Su, Alejandro Torres-Hernandez, Ryan Hickey, Krishna Shanbhogue, Kristen Renee Spencer, Karim Jarir Halazun, Augusto Villanueva · 2026 · Seminars in Liver Disease
- Bedeutung des Multidisziplinären Tumorboards in der Behandlung des hepatozellulären Karzinoms und des cholangiozellulären KarzinomsJörg Lehner, Thomas B. Brunner · 2026 · Die Onkologie
- Telehealth in Hepatocellular Carcinoma: Current Use and Future DirectionsLaura Salej Duran, Dabel Emebo, Jeremy Louissaint · 2026 · Current Hepatology Reports
- Modality-Specific and Multilevel Barriers to Curative Treatment for Early-Stage Hepatocellular CarcinomaAshwini Arvind, Lisa Quirk, Sneha Deodhar, Samuel Phen, Gi Giamarqo, Emma Jones, Celina Li, Kishore Botla, Christina Zhu, Sanjeeva Kalva et al. · 2026 · Liver Cancer
- Scientific, regulatory, and practical considerations for bringing hepatocellular carcinoma biomarkers into clinical practiceBlanca Botía Martínez-Artero, Eleonora Alimenti, James K. Carter, David James Pinato, Augusto Villanueva · 2026 · JHEP Reports
- Pandemic-Related Disruptions and Hepatocellular Carcinoma Surveillance in Safety-Net SettingsRobert J. Wong, Patricia Jones, Bolin Niu, Paulo Pinheiro, Mae Thamer, Onkar S. Kshirsagar, Y Zhang, Ronnie Fass, Daniela Prieto-Bello, Lisa Quirk et al. · 2026 · JAMA Network Open
- Socioeconomic Inequalities in Receipt of Curative‐Intent Treatment and Survival After Surveillance‐Detected Hepatocellular Carcinoma: A Nationwide Cohort StudyHannes Hagström, Jeffrey Victor Lazarus, Malin Sternby Eilard, Adam Bergman, Magnus Rizell, Per Sandström, Juan Vaz · 2026 · Alimentary Pharmacology & Therapeutics
- Letter to the Editor: Origin recognition complex subunit 1 as a biomarker in hepatitis B virus-related hepatocellular carcinoma: Promises and pitfallsLian-Bang Wang, Xi-Ming Wang, Xin-Ya Zhao, Gong‐Zheng Wang · 2026 · World Journal of Gastroenterology
- Global disparities in hepatocellular carcinoma care: insights from the ESGAR Global Abdominal Imaging ForumRoberto Cannella, Federica Vernuccio, Cäcilia S. Reiner, Katja N. De Paepe, Giuseppe Brancatelli, Valérie Vilgrain, Marc Zins, Damian Tolan · 2026 · European Radiology
- FROM BIOMARKERS TO PRECISION SURVEILLANCE: A SOCIO-TECHNICAL REVIEW OF NON-INVASIVE HEPATOCELLULAR CARCINOMA SCREENING IN CIRRHOSISKamil Chudzicki, Michał Babicz, Oliwer Muller, Jagoda Pałubska, Katarzyna Rosa, Agata Słoma, Anna Szot, Dominik Szydełko, Martyna Szymczyk, Paweł Żurek · 2026 · International Journal of Innovative Technologies in Social Science
- Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populationsNeehar D. Parikh, Chun-Chi Liu, Matthew DeMaio, Angela H. Yeh, Mary L. Stackpole, S Li, Vatche Garen Agopian, Wenyuan Li, Xianghong Jasmine Zhou, Xiaohui Ni et al. · 2026 · Hepatology Communications
- A bibliometric analysis of hepatocellular carcinoma screening in high risk populationsChengdian Lan, Dan-Lan Lian, Cui-Ling Huang · 2026 · Discover Oncology
- The Promise of Machine Learning–Based Population Screening for Hepatocellular CarcinomaZachariah H. Foda · 2026 · Cancer Discovery
- Hepatocellular carcinoma ultrasound surveillance adherence and outcomes in the UK: a multicentre retrospective service evaluationEdward Wigmore, Nagushan Abimanue, Tom Parry, Aiman Aslam, Jake E. Cowen, Anmol Gangi, Aloysious Dominic Aravinthan, James M Franklin · 2026 · Frontline Gastroenterology
- Proportion of time covered determines real-world hepatocellular carcinoma surveillance adherence and is associated with curative treatment: a single-centre retrospective deep diveChristopher Mysko, Azita Rajai, Kevin Kuriakose, Darren Griffiths, Stephanie Landi, Huw Purssell, Oliver Street, Deepankar Gahloth, A J Allen, Katherine Siaoa et al. · 2026 · Frontline Gastroenterology
- Patient experiences, understanding of and barriers to hepatocellular carcinoma ultrasound surveillance: a multicentre United Kingdom (UK) surveyAiman Aslam, J. Wong, Jonathan IF Jackson, Jason Kei Chak Mak, Michelle Dinsey, Ruth Reeve, Anmol Gangi, Aloysious Dominic Aravinthan, James M Franklin, Bushra Ali et al. · 2026 · Clinical Radiology
- Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta‐AnalysisC. K. Wallace, Devin Razavi‐Shearer, Samantha Hall, Tarik Asselah, Cary James, Loreta Anesti Kondili, Shyam Kottilil, Daniel Low‐Beer, Poonam Mathur, Junko Tanaka et al. · 2026 · Journal of Viral Hepatitis
- Performance of ASAP, LG2m, and GP73 for HCC Detection in Patients with CirrhosisMohammad Jarrah, Mohammed Al-Hasan, Mariadelcarmen Yanez, Maria V. Yow, Eunice Amador, Diya Kar, Fouzia Ahmed, Nicole E. Rich, S Deodhar, Jenna Bedrava et al. · 2026 · Cancers
- Artificial intelligence in hepatocellular carcinoma diagnosis and AI-assisted treatment support: Current landscape and future directionsQuan-Kai Lei, Tong-Xv Wu, Chu-Long Zhang, Yun‐Wen Zheng · 2026 · Liver Research
- Multi-Target HCC Blood Test Demonstrates Consistent Performance Across Subgroups of Patients with Chronic Liver DiseaseAmit G. Singal, Mark Camardo, Janelle J. Bruinsma, Elle Kielar‐Grevstad, Naga Chalasani, Binu V. John · 2026 · Cancers
- MRI of Hepatocellular Carcinoma: Cross-regional Perspectives on Trends and OpportunitiesCher Heng Tan, Hanyu Jiang, Yuancheng Wang, Hsien Min Low, Christopher L. Welle, Shuwei Zhou, Giuseppe Brancatelli, Sudhakar Kundapur Venkatesh, Jeong Min Lee · 2026 · Radiographics
- Surveillance for Hepatocellular Carcinoma in Patients at High RiskKathryn Jane Fowler, Aya Kamaya, Shuchi K. Rodgers, Danielle E. Kruse, Mustafa Rifaat Bashir, Guruveer S. Bhamra, Eun Sun Choi, Ahmed El Kaffas, Amit G. Singal, Hyo Jung Park et al. · 2026 · Radiographics
- Inequalities in hepatocellular carcinoma (HCC) surveillance uptake in London: a UK multicentre cohort studyMaria Qurashi, Varsha Chaitanya-Bhide, Shahid Ahmed Khan, Nina Stafford, Jayshri Shah, Luke David Tyson, Zinu Philipose, Hooshang Izadi, Rohini Sharma · 2026 · BMJ Public Health